Trial Profile
Phase 2 Randomized Study Comparing Two Dose Schedules of Ezatiostat Hydrochloride (Telintra, TLK199 Tablets) in Low to Intermediate-1 Risk Myelodysplastic Syndrome (MDS).
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 15 Dec 2011
Price :
$35
*
At a glance
- Drugs Ezatiostat (Primary)
- Indications Myelodysplastic syndromes
- Focus Therapeutic Use
- Sponsors Telik
- 13 Dec 2011 Results presented at the 53rd Annual Meeting and Exposition of the American Society of Hematology, according to a Telik media release.
- 29 Sep 2011 Results publised online in Cancer.
- 01 Sep 2011 Results published in the Cancer.